Diazyme Beta-Hydroxybutyrate (BHB) Assay

Diazyme has launched an enzymatic BHB Assay for the quantitative determination of beta-hydroxybutyrate in human serum or plasma. The assay is a dual vial liquid-stable reagent used with clinical chemistry analyzers. Healthcare professionals use measurements of BHB and blood glucose to assess the severity of diabetic coma. They use BHB measurements to guide the monitoring of patients, who are taking insulin therapy, for diabetic ketoacidosis, and for the testing of patients who present to the emergency room with documented hypoglycemia, acidosis, alcohol ingestion, or an unexplained increase in the anion gap.